Novavax Inc
NVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001000694
No open-market purchases or sales by Novavax Inc insiders were filed in the last 90 days; 267 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; Coatue Management is the only superinvestor holding it.
Superinvestors holding NVAX, Q2 2026
1 superinvestor reports holding Novavax Inc on Form 13F, worth $36.1M in total. Weight is Novavax Inc's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Coatue ManagementPhilippe Laffont | 0.1% | 3,836,986 | $36.1M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of NVAX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
1 superinvestor holding at quarter end
Q4 2025
0 superinvestors holding at quarter end
- Sold out
- Coatue Management
Q1 2025
1 superinvestor holding at quarter end
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Coatue Management
Q3 2024
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−15.3%)
Q2 2024
1 superinvestor holding at quarter end
- Added
- Coatue Management (+72.7%)
Q4 2023
1 superinvestor holding at quarter end
Q3 2023
0 superinvestors holding at quarter end
- Sold out
- Coatue Management
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−41.2%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- Coatue Management (+480.8%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−44.5%)
Q3 2022
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−55.9%)
Q2 2022
1 superinvestor holding at quarter end
- Added
- Coatue Management (+40.6%)
Q1 2022
1 superinvestor holding at quarter end